Archaeologists Make Groundbreaking Easter Island Discovery
Rapa Nui has long been seen as the epitome of a remote community, with historical records indicating that it developed in isolation without other Polynesian communities after it was established in 1200 A.D. However, the new research has found that Rapa Nui was influential in the development of other East Polynesian cultures and influenced the passing of some ceremonial ideals across the Pacific. Using radiocarbon dating, experts in Pacific archaeology Paul Wallin and Helene Martinsson-Wallin found that marae temple structures—intricate rectangular clearings which were used for community ceremonies—originated on Rapa Nui rather than on one of the connected islands, as was previously believed.
'The most important finding is that, based on C-14 dating, we can observe an initial west-to-east spread of ritual ideas," Wallin explained. "However, the complex, unified ritual spaces (known as marae) show earlier dates in the east."The results show that the Polynesian islands were far more interconnected and sophisticated than previously thought. It is believed that since ceremonial practices made their way from Rapa Nui to other Pacific settlements indicates a high level of maritime activity operating in the Polynesian islands, which pushes against any ideas of isolationism.
"The migration process from West Polynesian core areas such as Tonga and Samoa to East Polynesia is not disputed here," the study reads. "Still, the static west-to-east colonization and dispersal suggested for East Polynesia and the idea that Rapa Nui was only colonized once in the past and developed in isolation is challenged."
The study has largely reconceived how history views Rapa Nui and the Polynesian islands, and challenges commonly accepted ideas about the movement and development of ritual temple sites in East Polynesia," according to Wallen. 'The findings suggest a more complex pattern than previously thought. Initially, it has been shown that ritual ideas spread from west to east. Later, more elaborate temple structures developed on Easter Island, which then influenced other parts of East Polynesia in an east-to-west movement."Archaeologists Make Groundbreaking Easter Island Discovery first appeared on Men's Journal on Jul 9, 2025
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
a day ago
- Yahoo
Teeth marks suggest 'terror bird' was killed by reptile 13 million years ago
Teeth marks made on the leg bone of a large avian reptile known as a terror bird 13 million years ago suggest an even bigger predator may have killed it, scientists say. Terror birds were top predators - they could be taller than a human and had powerful legs and hooked, flesh-ripping beaks. Palaeontologists in Colombia matched teeth marks on the fossilised leg bone of one of these fearsome birds to a caiman, or a crocodile-like reptile. 3D digital scans of the bites allowed the scientists to reconstruct what they believe was a "battle to the death" that the terror bird did not survive. The new study, published in the journal Biology Letters, compared the size and shape of the teeth marks to the skulls and teeth of crocodile-like predators in museum collections. It provides rare evidence, the researchers say, of an interaction between two extinct top predators at the time. The leg bone the scientists studied was first unearthed more than 15 years ago in Colombia's Tatacoa Desert. When the bird lived in the swamps of that area 13 million years ago, it would have been about 2.5m tall and would have used its legs and beak to hold down and rip at its prey. What the scientists are not able to prove conclusively is whether this particular, unfortunate terror bird was killed in the attack, or if the caiman scavenged its remains. "There is no sign of healing in the bite marks on the bone," explained lead researcher Andres Link from the Universidad de Los Andes in Bogotá, Colombia. "So if it wasn't already dead, it died in the attack. That was the last day that bird was on this planet - then a piece of its leg bone was found 13 million years later." The Tatacoa Desert is home to rich deposits of fossils from an epoch known as the Middle Miocene. At that time, it was a humid swamp, where river sediments trapped and fossilised the bones of dead animals, resulting in the preserved remains found there today. This particular bone was first discovered about 15 years ago by local fossil collector César Augusto Perdomo. The Colombian scientists worked closely with Mr Perdomo, studying and cataloging fossils that he has gathered in his museum. It was when scientists were working in the museum that they realised that this fist-sized piece of leg bone came from a terror bird. That was an exciting discovery - terror bird fossils are rare. But Dr Link and his colleagues were also fascinated by the puncture marks in the bone, which had clearly been made by the teeth of another powerful predator. This new analysis of the marks revealed that they most closely match an extinct caiman species called Purussaurus neivensis, a crocodilian that would have been up to five metres long. The researchers say it would have ambushed its prey from the water's edge, much like crocodiles and caimans do today. "I would imagine it was waiting for prey to to be nearby," said Dr Link. If this was indeed a battle between two apex predators, Dr Link says that provides insight into an ancient ecosystem. It reveals that ferocious terror birds were much more vulnerable to predators than previously thought. "Every piece of a body helps us to understand so much about life on the planet in the past," Dr Link told BBC News. "That's something that amazes me - how one tiny bone can complete the story."
Yahoo
2 days ago
- Yahoo
AstraZeneca's Tagrisso combo shows OS improvement in Phase III NSCLC trial
AstraZeneca's Tagrisso (osimertinib) combined with pemetrexed and platinum-based chemotherapy has shown improvement in overall survival (OS) for those with first-line locally advanced or metastatic epidermal growth factor receptor-mutated (EGFRm) non-small cell lung cancer (NSCLC). According to the final analysis of the randomised Phase III trial, FLAURA2, it demonstrated a consistent survival benefit, echoing interim OS outcomes and building upon the earlier reported longest median progression-free survival (PFS) data for this setting. The combo showed OS improvements in the open-label, global, multi-centre trial when compared against Tagrisso as a single agent for this patient group. Subjects in the trial received 80mg of Tagrisso daily in oral tablet form, combined with a chemotherapy regimen. The chemotherapy included pemetrexed at a dosage of 500mg/m² and either cisplatin at 75mg/m² or carboplatin (AUC5) administered every three weeks for a total of four cycles. After completing the cycles, the treatment continued with Tagrisso alongside maintenance doses of pemetrexed, also given every three weeks. A total of 557 subjects were enrolled in the trial in more than 150 centres across over 20 nations, including in Asia, Europe, South America, and the US. PFS is the primary endpoint of the trial. The combination therapy's safety profile remained manageable, aligning with known profiles of the individual medicines. According to the company, the trial recorded higher adverse event rates in the combination arm, attributed to expected chemotherapy-related effects. Discontinuation rates due to adverse events remained low. These findings are set to be presented at an upcoming medical meeting and will be communicated to global regulatory bodies. AstraZeneca oncology haematology R&D executive vice-president Susan Galbraith said: 'These exciting overall survival results add to the extensive evidence supporting Tagrisso as the backbone therapy in EGFR-mutated lung cancer, demonstrating that Tagrisso plus chemotherapy can significantly extend survival in the first-line advanced setting, in addition to prior trials showing survival benefits as monotherapy in both early stage and advanced disease.' More than 80 nations, including the European Union (EU), the US, Japan, and China, have currently approved Tagrisso + chemotherapy based on the FLAURA2 trial data. In 2023, AstraZeneca reported positive outcomes from the ADAURA Phase III trial of Tagrisso in the adjuvant treatment of individuals with Stage IB, II, IIIA EGFRm NSCLC. "AstraZeneca's Tagrisso combo shows OS improvement in Phase III NSCLC trial" was originally created and published by Clinical Trials Arena, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Sign in to access your portfolio


Forbes
2 days ago
- Forbes
Don't Miss Jupiter And A Crescent Moon Shining Together This Week
Picture of the waxing crescent moon in conjunction with planet Jupiter, seen from Montevideo after ... More sunset on February 22, 2023. (Photo by Mariana SUAREZ / AFP) (Photo by MARIANA SUAREZ/AFP via Getty Images)Wednesday, July 23: Crescent Moon And Jupiter